These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38042769)

  • 21. Long non-coding RNA HAND2-AS1 delays cervical cancer progression via its regulation on the microRNA-21-5p/TIMP3/VEGFA axis.
    Gao Y; Zou T; Liang W; Zhang Z; Qie M
    Cancer Gene Ther; 2021 Jun; 28(6):619-633. PubMed ID: 33139818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. lncRNA HAND2-AS1 inhibits cancer cell proliferation, migration and invasion by downregulating ROCK1 in HPV-positive and negative cervical squamous cell carcinoma.
    Jin L; Ji J; Shi L; Jin S; Pei L
    Exp Ther Med; 2019 Oct; 18(4):2512-2518. PubMed ID: 31555362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy.
    Huang Z; Wang Z; Xia H; Ge Z; Yu L; Li J; Bao H; Liang Z; Cui Y; Xu Y
    Clin Chim Acta; 2023 Jan; 539():162-169. PubMed ID: 36528049
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Gao X; Zhang S; Wang X
    DNA Cell Biol; 2022 Jun; 41(6):600-605. PubMed ID: 35575749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. lncRNA HAND2-AS1 overexpression inhibits cancer cell proliferation in hepatocellular carcinoma by downregulating RUNX2 expression.
    Jing GY; Zheng XZ; Ji XX
    J Clin Lab Anal; 2021 Apr; 35(4):e23717. PubMed ID: 33566427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review on the role of gamma-butyrobetaine hydroxylase 1 antisense RNA 1 in the carcinogenesis and tumor progression.
    Hu J; Liu J; Zhou S; Luo H
    Cancer Cell Int; 2023 Nov; 23(1):263. PubMed ID: 37925403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of chronic myeloid leukemia cells by sponging with micRNA-1275.
    Yang JR; Shi MX; Zeng Y
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2103-2111. PubMed ID: 30915755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis.
    Bi HQ; Li ZH; Zhang H
    Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):567-574. PubMed ID: 32224127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p.
    Chen J; Lin Y; Jia Y; Xu T; Wu F; Jin Y
    J Cell Physiol; 2019 Dec; 234(12):23421-23436. PubMed ID: 31222748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. lncRNA HAND2-AS1 Inhibits Liver Cancer Cell Proliferation and Migration by Upregulating SOCS5 to Inactivate the JAK-STAT Pathway.
    Yan D; Jin F; Lin Y
    Cancer Biother Radiopharm; 2020 Mar; 35(2):143-152. PubMed ID: 32155348
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis.
    Wu L; Liao W; Wang X; Zhao Y; Pang J; Chen Y; Yang H; He Y
    Bioengineered; 2021 Dec; 12(2):10302-10318. PubMed ID: 34709970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of key lncRNAs in the tumorigenesis of intraductal pancreatic mucinous neoplasm by coexpression network analysis.
    Ding J; Li Y; Zhang Y; Fan B; Li Q; Zhang J; Zhang J
    Cancer Med; 2020 Jun; 9(11):3840-3851. PubMed ID: 32239802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA RARA-AS1 could serve as a novel prognostic biomarker in pan-cancer and promote proliferation and migration in glioblastoma.
    Huang Y; Deng S; Jiang Q; Shi J
    Sci Rep; 2023 Oct; 13(1):17376. PubMed ID: 37833349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA HAND2-AS1 promotes liver cancer stem cell self-renewal via BMP signaling.
    Wang Y; Zhu P; Luo J; Wang J; Liu Z; Wu W; Du Y; Ye B; Wang D; He L; Ren W; Wang J; Sun X; Chen R; Tian Y; Fan Z
    EMBO J; 2019 Sep; 38(17):e101110. PubMed ID: 31334575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of ZFPM2-AS1 prognostic value, immune microenvironment, drug sensitivity, and co-expression network: from gastric adenocarcinoma to pan-cancers.
    Chen D; Wang M; Jiang X; Xiong Z
    Discov Oncol; 2022 Apr; 13(1):24. PubMed ID: 35416526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA HAND2-AS1 targets glucose metabolism and inhibits cancer cell proliferation in osteosarcoma.
    Chen S; Xu X; Lu S; Hu B
    Oncol Lett; 2019 Aug; 18(2):1323-1329. PubMed ID: 31423193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA HAND2-AS1 is downregulated in osteoarthritis and regulates IL-6 expression in chondrocytes.
    Si Z; Zhou S; Shen Z; Luan F; Yan J
    J Orthop Surg Res; 2021 Jan; 16(1):68. PubMed ID: 33468183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA HAND2-AS1 restrains proliferation and metastasis of breast cancer cells through sponging miR-1275 and promoting SOX7.
    Wang Y; Cai X
    Cancer Biomark; 2020; 27(1):85-94. PubMed ID: 31683462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Non-Coding RNA HAND2-AS1 Inhibits Growth and Migration of Gastric Cancer Cells Through Regulating the miR-590-3p/KCNT2 Axis.
    Yu L; Li H; Li Z; Jia J; Wu Z; Wang M; Li F; Feng Z; Xia H; Gao G
    Onco Targets Ther; 2020; 13():3187-3196. PubMed ID: 32368078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum lncRNA HAND2-AS1 is downregulated in diabetic patients with chronic renal failure and ameliorates cell apoptosis.
    Dong C; Liu S; Li Y; Cui Y
    Diabetol Metab Syndr; 2020; 12():39. PubMed ID: 32411303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.